FDA food advisory committee working group to discuss Ma Huang adverse events.
This article was originally published in The Tan Sheet
Executive Summary
MA HUANG SAFETY TO BE REVIEWED BY FDA FOOD ADVISORY COMMITTEE WORKING GROUP in a two-day meeting scheduled for Oct. 11-12. The agency publicly indicated its intention to review dietary supplements containing natural ephedra in a Sept. 21 Federal Register notice announcing the availability of adverse event reports related to "food products" containing ephedrine alkaloids. FDA said it has received over 300 ephedrine-related reports.